{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:29:01Z","timestamp":1791404941082,"version":"4.3.3"},"reference-count":168,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jaut.2015.04.006","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T10:16:37Z","timestamp":1431944197000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":326,"special_numbering":"C","title":["Interleukin-17 and innate immunity in infections and chronic inflammation"],"prefix":"10.1016","volume":"60","author":[{"given":"Natasa","family":"Isailovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Daigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-0376","authenticated-orcid":false,"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2015.04.006_bib1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"Medzhitov","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib2","doi-asserted-by":"crossref","first-page":"d12","DOI":"10.2741\/A171","article-title":"Cytokines in acute and chronic inflammation","volume":"2","author":"Feghali","year":"1997","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jaut.2015.04.006_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/intimm\/dxp021","article-title":"Th17 cells: from precursors to players in inflammation and infection","volume":"21","author":"Awasthi","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1398-9995.1992.tb00662.x","article-title":"Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy","volume":"47","author":"Del Prete","year":"1992","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2015.04.006_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/rr40","article-title":"Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists","volume":"2","author":"Steinke","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2015.04.006_bib7","doi-asserted-by":"crossref","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2013.10.004","article-title":"Th9 cells, new players in adaptive immunity","volume":"35","author":"Schmitt","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib10","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J.\u00a0Clin. Investigation"},{"key":"10.1016\/j.jaut.2015.04.006_bib11","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jaut.2015.04.006_bib12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cyto.2013.07.022","article-title":"IL-17 family: cytokines, receptors and signaling","volume":"64","author":"Gu","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2015.04.006_bib14","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","article-title":"CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene","volume":"150","author":"Rouvier","year":"1993","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature11984","article-title":"Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1","volume":"496","author":"Wu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2015.04.006_bib16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature11868","article-title":"Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells","volume":"496","author":"Kleinewietfeld","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2015.04.006_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2015.04.006_bib20","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/embor.2011.248","article-title":"Regulation and function of innate and adaptive interleukin-17-producing cells","volume":"13","author":"Hirota","year":"2012","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jaut.2015.04.006_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.1100123","article-title":"Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis","volume":"187","author":"Lin","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20072713","article-title":"Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22","volume":"206","author":"Takatori","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.20091509","article-title":"Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells","volume":"207","author":"Crellin","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20061551","article-title":"Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia","volume":"204","author":"Michel","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A\u00a0human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2015.04.006_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-010-9369-6","article-title":"The IL-17 family cytokines in immunity and disease","volume":"30","author":"Pappu","year":"2010","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib28","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1084\/jem.20101712","article-title":"IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease","volume":"208","author":"Geremia","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2008.03.006","article-title":"MPO-ANCA induces IL-17 production by activated neutrophils in\u00a0vitro via classical complement pathway-dependent manner","volume":"31","author":"Hoshino","year":"2008","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.04.006_bib30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Villanova","year":"2014","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib31","doi-asserted-by":"crossref","first-page":"25487","DOI":"10.1074\/jbc.M111.240671","article-title":"Tumor necrosis factor alpha-mediated induction of interleukin 17C in human keratinocytes is controlled by nuclear factor kappaB","volume":"286","author":"Johansen","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2015.04.006_bib32","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","article-title":"Mast cells express IL-17A in rheumatoid arthritis synovium","volume":"184","author":"Hueber","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/cr.2014.92","article-title":"Targeting Th17 cells in immune diseases","volume":"24","author":"Dong","year":"2014","journal-title":"Cell. Res."},{"key":"10.1016\/j.jaut.2015.04.006_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2174\/187152812800392805","article-title":"The IL23\/Th17 pathway as a therapeutic target in chronic inflammatory diseases","volume":"11","author":"Toussirot","year":"2012","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.jaut.2015.04.006_bib35","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.4049\/jimmunol.170.4.2153","article-title":"Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system","volume":"170","author":"Zhang","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2567.2008.03017.x","article-title":"Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens","volume":"126","author":"Curtis","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2015.04.006_bib37","doi-asserted-by":"crossref","first-page":"267971","DOI":"10.1155\/2013\/267971","article-title":"IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection","volume":"2013","author":"Tsai","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2014.07.003","article-title":"Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis - Xenograft model","volume":"55","author":"Kundu-Raychaudhuri","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.04.006_bib40","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","article-title":"IL-12 and IL-23: master regulators of innate and adaptive immunity","volume":"202","author":"Langrish","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2015.04.006_bib41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/sj.icb.7100114","article-title":"Autoimmunity: IL-21: a new player in Th17-cell differentiation","volume":"85","author":"Deenick","year":"2007","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jaut.2015.04.006_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12026-007-8014-9","article-title":"Th17 cells: a new fate for differentiating helper T cells","volume":"41","author":"Chen","year":"2008","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2015.04.006_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib44","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1084\/jem.171.5.1597","article-title":"Evidence for extrathymic changes in the T cell receptor gamma\/delta repertoire","volume":"171","author":"Parker","year":"1990","journal-title":"J.\u00a0Exp.\u00a0Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib45","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib46","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/343754a0","article-title":"Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia","volume":"343","author":"Itohara","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2015.04.006_bib47","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1084\/jem.170.5.1569","article-title":"Intraepithelial lymphocytes. Anatomical site, not T\u00a0cell receptor form, dictates phenotype and function","volume":"170","author":"Goodman","year":"1989","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib48","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.4049\/jimmunol.1100427","article-title":"Cutting edge: identification of a motile IL-17-producing gammadelta T cell population in the dermis","volume":"186","author":"Gray","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib49","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/ni.1717","article-title":"CD27 is a thymic determinant of the balance between interferon-gamma- and interleukin 17-producing gammadelta T cell subsets","volume":"10","author":"Ribot","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib50","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1002\/eji.200939922","article-title":"CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells","volume":"39","author":"Haas","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.immuni.2008.04.022","article-title":"Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma","volume":"29","author":"Jensen","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1749-6632.2011.06355.x","article-title":"Development and function of interleukin 17-producing gammadelta T cells","volume":"1247","author":"Korn","year":"2012","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.jaut.2015.04.006_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood-2011-01-331298","article-title":"Differentiation, phenotype, and function of interleukin-17-producing human Vgamma9Vdelta2 T cells","volume":"118","author":"Caccamo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2015.04.006_bib54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.coi.2007.02.009","article-title":"On the road: progress in finding the unique pathway of invariant NKT cell differentiation","volume":"19","author":"Kronenberg","year":"2007","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib55","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.1220601110","article-title":"Recognition of microbial and mammalian phospholipid antigens by NKT cells with diverse TCRs","volume":"110","author":"Tatituri","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.jaut.2015.04.006_bib56","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/eji.200940257","article-title":"CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC","volume":"40","author":"Maggi","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri3328","article-title":"Recognition of CD1d-restricted antigens by natural killer T cells","volume":"12","author":"Rossjohn","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib58","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.4049\/jimmunol.1003043","article-title":"Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells","volume":"186","author":"Moreira-Teixeira","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2013.11.003","article-title":"Innate lymphoid cells: new paradigm in immunology of inflammation","volume":"157","author":"Kumar","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2015.04.006_bib60","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/onc.2008.267","article-title":"NK cells and cancer immunosurveillance","volume":"27","author":"Waldhauer","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jaut.2015.04.006_bib61","first-page":"27","article-title":"NK cell autoreactivity and autoimmune diseases","volume":"5","author":"Poggi","year":"2014","journal-title":"Front.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib62","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.0901843","article-title":"IL-6 promotes NK cell production of IL-17 during toxoplasmosis","volume":"184","author":"Passos","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib63","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ni.1681","article-title":"Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin","volume":"10","author":"Luci","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib64","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.4049\/jimmunol.0901935","article-title":"The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium","volume":"183","author":"Satoh-Takayama","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/978-1-60761-362-6_32","article-title":"Isolation of NK cells and NK-like cells from the intestinal lamina propria","volume":"612","author":"Sanos","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jaut.2015.04.006_bib66","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/art.10605","article-title":"Cell-surface expression and immune receptor recognition of HLA-B27 homodimers","volume":"46","author":"Kollnberger","year":"2002","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.jaut.2015.04.006_bib67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/cyto.b.20549","article-title":"Evaluation of degranulation and cytokine production in natural killer cells from spondyloarthritis patients at single-cell level","volume":"80","author":"Scrivo","year":"2011","journal-title":"Cytom. B Clin. Cytom."},{"key":"10.1016\/j.jaut.2015.04.006_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2249.2009.03932.x","article-title":"Lymphoid tissue inducer cells: architects of CD4 immune responses in mice and men","volume":"157","author":"Kim","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ni.1668","article-title":"Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells","volume":"10","author":"Cupedo","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib70","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.1202924","article-title":"Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection","volume":"190","author":"Gladiator","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib71","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2015.04.006_bib72","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ni.2002","article-title":"RORgammat+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota","volume":"12","author":"Sawa","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.it.2011.06.008","article-title":"Neutrophils cascading their way to inflammation","volume":"32","author":"Sadik","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib74","first-page":"519","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev."},{"key":"10.1016\/j.jaut.2015.04.006_bib75","first-page":"678","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated","volume":"7","author":"Ley","year":"2007","journal-title":"Nat. Rev."},{"key":"10.1016\/j.jaut.2015.04.006_bib76","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ni.2156","article-title":"IL-17C regulates the innate immune function of epithelial cells in an autocrine manner","volume":"12","author":"Ramirez-Carrozzi","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib77","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1172\/JCI38702","article-title":"IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury","volume":"120","author":"Li","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jaut.2015.04.006_bib78","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1152\/physrev.1997.77.4.1033","article-title":"Mast cells","volume":"77","author":"Metcalfe","year":"1997","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jaut.2015.04.006_bib79","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaci.2009.11.017","article-title":"IgE, mast cells, basophils, and eosinophils","volume":"125","author":"Stone","year":"2010","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib80","first-page":"S1130","article-title":"Association of Smoking with acute phase Reactants and molecules involved in bone formation in patients with ankylosing spondylitis","volume":"66","author":"Sakellariou","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib81","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.4049\/jimmunol.1203017","article-title":"IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids","volume":"190","author":"Zizzo","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib82","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and\u00a0is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib83","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ni.3023","article-title":"Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage","volume":"15","author":"Sutherland","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib84","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib85","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/jid.2014.268","article-title":"IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood","volume":"134","author":"Wang","year":"2014","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib86","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses","volume":"30","author":"Ishigame","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib87","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1074\/jbc.M210429200","article-title":"Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine\/autocrine loop","volume":"278","author":"Chen","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2015.04.006_bib88","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells\u00a0and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib89","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.4049\/jimmunol.160.7.3513","article-title":"IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages","volume":"160","author":"Jovanovic","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib90","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib91","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.it.2012.02.008","article-title":"Regulation of epithelial immunity by IL-17 family cytokines","volume":"33","author":"Pappu","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib92","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20061738","article-title":"IL-25 regulates Th17 function in autoimmune inflammation","volume":"204","author":"Kleinschek","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib93","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cytogfr.2010.10.002","article-title":"IL-17 family member cytokines: regulation and function in innate immunity","volume":"21","author":"Reynolds","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jaut.2015.04.006_bib94","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cyto.2011.07.007","article-title":"Caspase-1-processed IL-1 family cytokines play a vital role in driving innate IL-17","volume":"56","author":"Dungan","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.jaut.2015.04.006_bib95","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0016-5085(00)70351-9","article-title":"Claudins regulate the intestinal barrier in response to immune mediators","volume":"118","author":"Kinugasa","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2015.04.006_bib96","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar2772","article-title":"Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies","volume":"11","author":"Moran","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2015.04.006_bib97","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaut.2012.12.001","article-title":"The impact of genes on the occurrence of autoantibodies in rheumatoid arthritis. A study on disease discordant twin pairs","volume":"41","author":"Svendsen","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.04.006_bib98","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2014.01.027","article-title":"Diagnosis and classification of rheumatoid arthritis","volume":"48\u201349","author":"Kourilovitch","year":"2014","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.04.006_bib99","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1006\/cyto.2000.0681","article-title":"Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis","volume":"12","author":"Chabaud","year":"2000","journal-title":"Cytokine"},{"issue":"Suppl.\u00a017","key":"10.1016\/j.jaut.2015.04.006_bib100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00535-006-1926-7","article-title":"Interaction between interleukin-17-producing CD4+ T cells and colonic subepithelial myofibroblasts: what are they doing in mucosal inflammation?","volume":"42","author":"Andoh","year":"2007","journal-title":"J.\u00a0Gastroenterology"},{"key":"10.1016\/j.jaut.2015.04.006_bib101","first-page":"1023","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J. Official Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.jaut.2015.04.006_bib102","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from\u00a0mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2012.09.001","article-title":"Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes","volume":"40","author":"Liubchenko","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.04.006_bib104","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","article-title":"T\u00a0cell responses in psoriasis and psoriatic arthritis","volume":"14","author":"Diani","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2015.04.006_bib105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2013.01.001","article-title":"Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris","volume":"41","author":"Zhang","year":"2013","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2015.04.006_bib106","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.autrev.2012.11.009","article-title":"Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target?","volume":"12","author":"Modena","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2015.04.006_bib107","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.4049\/jimmunol.179.8.5576","article-title":"Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells","volume":"179","author":"Roark","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib108","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12026-012-8364-9","article-title":"A\u00a0canonical Vgamma4Vdelta4+ gammadelta T cell population with distinct stimulation requirements which promotes the Th17 response","volume":"55","author":"Roark","year":"2013","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2015.04.006_bib109","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.24687","article-title":"Gamma\/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.jaut.2015.04.006_bib110","first-page":"1","article-title":"T\u00a0cell receptor and function cosegregate in gamma-delta T cell subsets","volume":"79","author":"O'Brien","year":"2001","journal-title":"Chem. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib111","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.4049\/jimmunol.1003370","article-title":"Th17 cells, not IL-17+ gammadelta T cells, drive arthritic bone destruction in mice and humans","volume":"186","author":"Pollinger","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib112","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/exd.12487","article-title":"Cellular sources of IL-17 in psoriasis: a paradigm shift?","volume":"23","author":"Keijsers","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib113","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/imm.12142","article-title":"Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis","volume":"141","author":"Kirkham","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2015.04.006_bib114","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11926-006-0063-x","article-title":"Animal models of psoriasis and psoriatic arthritis: an update","volume":"8","author":"Conrad","year":"2006","journal-title":"Curr. Rheumatol. Reports"},{"key":"10.1016\/j.jaut.2015.04.006_bib115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis","volume":"64","author":"Noordenbos","year":"2012","journal-title":"Arthritis Rheumatism"},{"key":"10.1016\/j.jaut.2015.04.006_bib116","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11010-011-1036-6","article-title":"IL-17 receptor and its functional significance in psoriatic arthritis","volume":"359","author":"Raychaudhuri","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jaut.2015.04.006_bib117","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/path.2667","article-title":"Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques","volume":"220","author":"de Boer","year":"2010","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.jaut.2015.04.006_bib118","doi-asserted-by":"crossref","unstructured":"Pantelyushin S, Haak S, Ingold B, Kulig P, Heppner FL, Navarini AA et\u00a0al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest.;122:2252\u20132256..","DOI":"10.1172\/JCI61862"},{"key":"10.1016\/j.jaut.2015.04.006_bib119","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2119\/2006-00003.Gulko","article-title":"Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis","volume":"11","author":"Batliwalla","year":"2005","journal-title":"Mol. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib120","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.4049\/jimmunol.180.6.4022","article-title":"Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection","volume":"180","author":"Bozza","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib121","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.immuni.2009.12.003","article-title":"The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation","volume":"32","author":"Gulen","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2015.04.006_bib122","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.4049\/jimmunol.1300828","article-title":"Toll IL-1R8\/single Ig IL-1-related receptor regulates psoriasiform inflammation through direct inhibition of innate IL-17A expression by gammadelta T cells","volume":"191","author":"Russell","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib123","doi-asserted-by":"crossref","unstructured":"Glitzner E, Korosec A, Brunner PM, Drobits B, Amberg N, Schonthaler HB et\u00a0al. Specific roles for dendritic cell subsets during initiation and progression of psoriasis. EMBO Mol. Med.;6:1312\u20131327..","DOI":"10.15252\/emmm.201404114"},{"key":"10.1016\/j.jaut.2015.04.006_bib124","doi-asserted-by":"crossref","unstructured":"Boltjes A, van Wijk F. Human dendritic cell functional specialization in steady-state and inflammation. Front. Immunol.;5:131..","DOI":"10.3389\/fimmu.2014.00131"},{"key":"10.1016\/j.jaut.2015.04.006_bib125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/eji.200839090","article-title":"IL-17 and anti-bacterial immunity: protection versus tissue damage","volume":"39","author":"Cooper","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib126","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni.2593","article-title":"IL-17-producing B cells combat parasites","volume":"14","author":"Leon","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib127","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.177.7.4662","article-title":"IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection","volume":"177","author":"Lockhart","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib128","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.0903332","article-title":"Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung","volume":"184","author":"Okamoto Yoshida","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib129","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.4049\/jimmunol.178.6.3786","article-title":"IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection","volume":"178","author":"Umemura","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib130","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2012.05.008","article-title":"IL-17 and gammadelta T-lymphocytes play a critical role in innate immunity against Nocardia asteroides GUH-2","volume":"14","author":"Tam","year":"2012","journal-title":"Microbes Infect.\/Institut. Pasteur."},{"key":"10.1016\/j.jaut.2015.04.006_bib131","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/2049-632X.12043","article-title":"The responses of gammadelta T-cells against acute Pseudomonas aeruginosa pulmonary infection in mice via interleukin-17","volume":"68","author":"Liu","year":"2013","journal-title":"Pathogens Dis."},{"key":"10.1016\/j.jaut.2015.04.006_bib132","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.4049\/jimmunol.178.7.4466","article-title":"Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production","volume":"178","author":"Shibata","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib133","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1172\/JCI40891","article-title":"IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice","volume":"120","author":"Cho","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jaut.2015.04.006_bib134","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.4049\/jimmunol.181.5.3456","article-title":"IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver","volume":"181","author":"Hamada","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2567.2008.02841.x","article-title":"Importance of murine Vdelta1gammadelta T cells expressing interferon-gamma and interleukin-17A in innate protection against Listeria monocytogenes infection","volume":"125","author":"Hamada","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2015.04.006_bib136","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/eji.201242891","article-title":"IL-17 plays a central role in initiating experimental Candida albicans infection in mouse corneas","volume":"43","author":"Zhang","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib137","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.4049\/jimmunol.1303281","article-title":"Intrahepatic innate lymphoid cells secrete IL-17A and IL-17F that are crucial for T cell priming in viral infection","volume":"192","author":"Jie","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib138","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/cmi.2008.25","article-title":"Interleukin 17-producing gamma delta T cells increased in patients with active pulmonary tuberculosis","volume":"5","author":"Peng","year":"2008","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib139","doi-asserted-by":"crossref","unstructured":"Asano T, Ichiki K, Koizumi S, Kaizu K, Hatori T, Fujino O et\u00a0al. IL-17 is elevated in cerebrospinal fluids in bacterial meningitis in children. Cytokine;51:101\u2013106..","DOI":"10.1016\/j.cyto.2010.03.001"},{"key":"10.1016\/j.jaut.2015.04.006_bib140","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12016-012-8307-1","article-title":"Role of IL-17 in psoriasis and psoriatic arthritis","volume":"44","author":"Raychaudhuri","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2015.04.006_bib141","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar4317","article-title":"Th17 and Th22 cells in psoriatic arthritis and psoriasis","volume":"15","author":"Benham","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2015.04.006_bib142","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/13543784.2013.806483","article-title":"IL-17 targeted therapies for psoriasis","volume":"22","author":"Chiricozzi","year":"2013","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.jaut.2015.04.006_bib143","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib144","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjd.12110","article-title":"Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study","volume":"168","author":"Papp","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.1200439","article-title":"Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity","volume":"332","author":"Puel","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaut.2015.04.006_bib146","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature06764","article-title":"Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome","volume":"452","author":"Milner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2015.04.006_bib147","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","article-title":"Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis","volume":"366","author":"Papp","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib148","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/annrheumdis-2012-201601","article-title":"Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study","volume":"72","author":"Genovese","year":"2013","journal-title":"Ann. Rheumatic Dis."},{"key":"10.1016\/j.jaut.2015.04.006_bib149","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3899\/jrheum.130637","article-title":"One-year efficacy and safety results of secukinumab in patients with rheumatoid arthritis: phase II, dose-finding, double-blind, randomized, placebo-controlled study","volume":"41","author":"Genovese","year":"2014","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib150","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.27334","article-title":"LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebo-controlled, proof-of-concept study","volume":"62","author":"Genovese","year":"2010","journal-title":"Arthritis Rheumat."},{"key":"10.1016\/j.jaut.2015.04.006_bib151","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.38617","article-title":"A\u00a0phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors","volume":"66","author":"Genovese","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib152","doi-asserted-by":"crossref","first-page":"R164","DOI":"10.1186\/ar4347","article-title":"A\u00a0phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis","volume":"15","author":"Martin","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2015.04.006_bib153","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis\u2013results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N.\u00a0Engl. J.\u00a0Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib154","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","article-title":"Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial","volume":"73","author":"McInnes","year":"2014","journal-title":"Ann. Rheumat. Dis."},{"key":"10.1016\/j.jaut.2015.04.006_bib155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40265-014-0191-y","article-title":"Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis","volume":"74","author":"Mease","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jaut.2015.04.006_bib156","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","article-title":"Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis","volume":"370","author":"Mease","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2015.04.006_bib157","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11926-011-0201-y","article-title":"Synovial tissue heterogeneity and peripheral blood biomarkers","volume":"13","author":"Bugatti","year":"2011","journal-title":"Curr. Rheumatol. Reports"},{"key":"10.1016\/j.jaut.2015.04.006_bib158","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/bjd.12331","article-title":"Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B\/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12\/23 blocker ustekinumab","volume":"169","author":"Talamonti","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib159","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/CS20140554","article-title":"Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine","volume":"128","author":"Rodriguez-Carrio","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jaut.2015.04.006_bib160","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3899\/jrheum.140327","article-title":"A\u00a0Simplified Baseline Prediction model for joint damage progression in rheumatoid arthritis: a Step toward personalized medicine","volume":"42","author":"de Punder","year":"2015","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib161","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/CE.S33940","article-title":"Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis","volume":"9","author":"Coimbra","year":"2014","journal-title":"Core Evid."},{"key":"10.1016\/j.jaut.2015.04.006_bib162","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaad.2014.07.048","article-title":"A\u00a052-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis","volume":"71","author":"Gordon","year":"2014","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.jaut.2015.04.006_bib163","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40265-015-0359-0","article-title":"Secukinumab: first global approval","volume":"75","author":"Sanford","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.jaut.2015.04.006_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-014-0042-5","article-title":"Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy","volume":"4","author":"Gisondi","year":"2014","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jaut.2015.04.006_bib165","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"Ritchlin","year":"2014","journal-title":"Ann. Rheumatic Dis."},{"key":"10.1016\/j.jaut.2015.04.006_bib166","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2217\/imt.13.81","article-title":"Ustekinumab for the treatment of Crohn's disease","volume":"5","author":"Khanna","year":"2013","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaut.2015.04.006_bib167","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/imt.14.101","article-title":"Efficacy and safety of emerging immunotherapies in psoriasis","volume":"7","author":"Yiu","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaut.2015.04.006_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.01.018","article-title":"Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial","author":"Krueger","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841115000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:11:19Z","timestamp":1760256679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841115000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":168,"alternative-id":["S0896841115000591"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2015.04.006","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-17 and innate immunity in infections and chronic inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2015.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}